M4MM

Health Canada Approves Jazz Pharmaceuticals’ Epidiolex

NEW YORK- Canada's federal health regulator, Health Canada, has recently approved Epidiolex, a cannabinoid-based medicine developed by Jazz Pharmaceuticals Canada. This approval positions Epidiolex as a supplementary therapy for certain rare and severe forms of ...

Arkansas and Rhode Island Cannabis Markets

LOS ANGELES- October 2023 witnessed a modest reduction in medical cannabis sales in Arkansas, reaching $22.5 million, a slight decrease from the same period in 2022. This data, sourced from the state's Department of Finance ...

Subscribe To Our Newsletter